Officiële publicaties Cerenis Therapeutics LIQUIDNET SYSTEMS

Aandelen

slotkoers LIQUIDNET SYSTEMS Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^EUR	-.--%		-.--%	-.--%

11/03	ABIONYX Pharma SA rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
15/02	ABIONYX Pharma SA bevestigt de klinische resultaten van de Fase 3-studie Aegis-Ii die de doeltreffendheid en veiligheid evalueert van CSL Behring's menselijk plasma-afgeleide apoA-I, CSL112.	CI

Monthly statement on voting rights	31/05	CO
Monthly statement on voting rights	31/05	CO
Combined general shareholders meeting	22/05	CO
1st quarter turnover	16/05	CO
1st quarter turnover	16/05	CO
Universal registration document	02/05	CO
Monthly statement on voting rights	30/04	CO
Monthly statement on voting rights	30/04	CO
Monthly statement on voting rights	31/03	CO
Monthly statement on voting rights	31/03	CO
Annual results	11/03	CO
Annual results	11/03	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	29/02	CO
Monthly statement on voting rights	31/01	CO
Changes in management and corporate officers	08/01	CO
Changes in management and corporate officers	08/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	30/11	CO
Threshold crossings	30/11	CO
3rd quarter turnover	16/11	CO
3rd quarter turnover	16/11	CO
Monthly statement on voting rights	31-10-23	CO